Rafferty Asset Management, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,940,573
-6.6%
251,125
+20.5%
0.05%
-2.1%
Q2 2023$8,497,247
+7.9%
208,368
-1.4%
0.05%
-9.4%
Q1 2023$7,878,431
-3.7%
211,388
-9.8%
0.05%
-22.1%
Q4 2022$8,180,449
+12.7%
234,464
+80.8%
0.07%
-11.7%
Q3 2022$7,256,000
+20.9%
129,659
+11.9%
0.08%
+40.0%
Q2 2022$6,000,000
-8.0%
115,919
+29.2%
0.06%
+41.0%
Q1 2022$6,520,000
+15.2%
89,721
+87.5%
0.04%
+30.0%
Q4 2021$5,658,000
+117.5%
47,854
+146.8%
0.03%
+66.7%
Q3 2021$2,601,000
-47.5%
19,391
-36.6%
0.02%
-41.9%
Q2 2021$4,952,000
+21.3%
30,582
-39.9%
0.03%
+10.7%
Q1 2021$4,081,000
+328.7%
50,855
+190.5%
0.03%
+211.1%
Q4 2020$952,000
-41.4%
17,504
-78.6%
0.01%
-55.0%
Q3 2020$1,624,000
+217.2%
81,665
+235.4%
0.02%
+185.7%
Q2 2020$512,000
-23.2%
24,346
-46.5%
0.01%
-30.0%
Q4 2019$667,000
-52.2%
45,492
-56.4%
0.01%
-54.5%
Q3 2019$1,394,000
-8.0%
104,450
+12.8%
0.02%
-18.5%
Q2 2019$1,516,000
+11.3%
92,590
+16.1%
0.03%
+22.7%
Q1 2019$1,362,00079,7190.02%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders